1

Medullary Thyroid Cancer Drugs Market is driven by Targeted Therapies

 News Discuss 
The medullary thyroid cancer drugs market is estimated to be valued at USD 172.9 Mn in 2025 and is expected to reach USD 354.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032. https://justpaste.me/Q2vN5

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News